Trevena Inc (TRVN)
0.4126
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.4295
+0.02
(+4.10%)
After-Hours: 20:00
Trevena Free Cash Flow: -33.08M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -33.08M |
| September 30, 2023 | -37.73M |
| June 30, 2023 | -39.44M |
| March 31, 2023 | -44.12M |
| December 31, 2022 | -51.50M |
| September 30, 2022 | -53.46M |
| June 30, 2022 | -53.96M |
| March 31, 2022 | -54.06M |
| December 31, 2021 | -50.21M |
| September 30, 2021 | -44.73M |
| June 30, 2021 | -36.31M |
| March 31, 2021 | -29.59M |
| December 31, 2020 | -21.39M |
| September 30, 2020 | -21.07M |
| June 30, 2020 | -24.50M |
| March 31, 2020 | -22.20M |
| December 31, 2019 | -23.67M |
| September 30, 2019 | -22.35M |
| June 30, 2019 | -20.36M |
| March 31, 2019 | -22.68M |
| December 31, 2018 | -25.54M |
| Date | Value |
|---|---|
| September 30, 2018 | -31.96M |
| June 30, 2018 | -40.87M |
| March 31, 2018 | -55.73M |
| December 31, 2017 | -74.75M |
| September 30, 2017 | -90.90M |
| June 30, 2017 | -102.47M |
| March 31, 2017 | -100.90M |
| December 31, 2016 | -92.16M |
| September 30, 2016 | -76.12M |
| June 30, 2016 | -63.47M |
| March 31, 2016 | -55.15M |
| December 31, 2015 | -40.45M |
| September 30, 2015 | -41.49M |
| June 30, 2015 | -40.69M |
| March 31, 2015 | -40.17M |
| December 31, 2014 | -40.22M |
| September 30, 2014 | -37.77M |
| June 30, 2014 | -33.38M |
| March 31, 2014 | -27.92M |
| December 31, 2013 | -24.38M |
Free Cash Flow Range, Past 5 Years
-54.06M
Minimum
Mar 2022
-20.36M
Maximum
Jun 2019
-35.99M
Average
-36.31M
Median
Jun 2021
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -4.15M |
| Palatin Technologies Inc | -26.75M |
| iBio Inc | -18.89M |
| Theriva Biologics Inc | -19.20M |
| Oragenics Inc | -7.291M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.985M |
| Cash from Investing (Quarterly) | -0.021M |
| Cash from Financing (Quarterly) | 4.029M |
| Free Cash Flow Per Share (Quarterly) | -0.3812 |
| Free Cash Flow to Equity (Quarterly) | -7.173M |
| Free Cash Flow to Firm (Quarterly) | -4.547M |
| Free Cash Flow Yield | -630.1% |